title: Mismatched unrelated alternative donors for hematological malignancies.
abstract: For the majority of hematologic malignancies allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment option. Sibling donors have been the standard for adult patients. Since there is not a suitable family donor for all patients, the need for alternative donors for HCT is great. Fortunately, the availability of unrelated volunteer donor registries has expanded over the years and the results of HCT with matched unrelated donors (MUD) are comparable to the results with matched related donors (MRD). Nevertheless, there are many patients lacking a well-matched donor. To increase the applicability of transplantation, alternative donors such as mismatched unrelated donors (MMURD), cord blood stem cell products and haploidentical related donors have been widely used. This review seeks to give insights into the use of MMUD donors for HCT and summarize the existing data.
authors.affiliation: Department of Hematology, Oncology and Stem Cell Transplantation, Albert-Ludwigs University Medical Center, Freiburg, Germany.
authors.forename: Henning
authors.initials: H
authors.lastname: Sebastian Schäfer
authors.affiliation: Department of Hematology, Oncology and Stem Cell Transplantation, Albert-Ludwigs University Medical Center, Freiburg, Germany. Electronic address: juergen.finke@uniklinik-freiburg.de.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Finke
mesh_terms: D006084:Graft Rejection; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D012008:Recurrence; D014184:Transplantation, Homologous; D061349:Unrelated Donors
keywords: Allogeneic transplantation; HSCT; MUD; Mismatch